SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Nuvo Research Inc
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Krikor who wrote (593)9/15/1997 4:49:00 PM
From: Pat Kelly   of 14101
 
WF10 granted full approval by Thailand government

Dimethaid Research Inc DMX
Shares issued 33,021,526 Sep 12 close $4.85
Mon 15 Sept 97 News Release
Mr Peter Block reports
The Thailand Ministry of Public Health has granted full approval for WF10 as an immune modulator for enhancement of cell-mediated immunity and treatment of radiation therapy complications. As a result, WF10 will be commercially available in Thailand for patients with immune deficiencies.
WF10 has been tested in two phase II trials in the US, one of which was completed in late 1995 and the other, a mechanism of action study, was completed earlier this year with the analysis currently being conducted.
Results from this latest study are expected later this year.
Dimethaid Research currently owns 20% of Oxo Chemie and holds all distribution rights to WF10 in Canada. Dimethaid is a pharmaceutical company engaged in the development and commercialization of innovative therapeutic products which work with the body's own healing mechanisms. The company's major product under clinical development, in addition to WF10, is
PENNSAID, a topical arthritis pain relief medication. Marketing approval for PENNSAID has been sought in both Canada and the UK.
(c) Copyright 1997 Canjex Publishing Ltd. canada-stockwatch.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News